ES8801198A1 - Un procedimiento para la preparacion de delta 22 o delta 23 -26,-26,26,27,27,27-hexafluoro-1alfa,25-dihidroxicolecalci- ferol - Google Patents

Un procedimiento para la preparacion de delta 22 o delta 23 -26,-26,26,27,27,27-hexafluoro-1alfa,25-dihidroxicolecalci- ferol

Info

Publication number
ES8801198A1
ES8801198A1 ES548910A ES548910A ES8801198A1 ES 8801198 A1 ES8801198 A1 ES 8801198A1 ES 548910 A ES548910 A ES 548910A ES 548910 A ES548910 A ES 548910A ES 8801198 A1 ES8801198 A1 ES 8801198A1
Authority
ES
Spain
Prior art keywords
preparation
compounds
cholecalciferol
cholecalciferol derivatives
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES548910A
Other languages
English (en)
Other versions
ES548910A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES548910A0 publication Critical patent/ES548910A0/es
Publication of ES8801198A1 publication Critical patent/ES8801198A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C7/00Purification; Separation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/44Halogenated unsaturated alcohols containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Analytical Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Water Supply & Treatment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DEL DELTA22 O DELTA23-26,26,26,27,27,27-HEXAFLUORO-1ALFA,25-DIHIDROXICOLECALCIFEROL. COMPRENDE: A) HACER REACCIONAR A 1R-1B(RX),3AA,4B,7AB OCTAHIDRO-1-6,6,6-TRIFLUORO-5-TRIMETILSILILOXI-5-TRIFLUOROMETIL-1-METIL-2-HEXENIL-7-A-METIL-H-INDEN-4-ONA DE FORMULA (II) CON OXIDO DE 35-(3A,5B,Z)-2-2-METILEN-3,5-BIS) (1,1-DIMETILETIL) DIMETILSILILOXI CICLOHEXILIDEN ETILDIFENILFOSFINA, EN TETRAHIDROFURANO Y EN ATMOSFERA INERTE; B) TRATAR AL COMPUESTO OBTENIDO EN A) CON FENORURO DE TETRABUTILAMONIO, PARA OBTENER UN COMPUESTO DE FORMULA (I). SIENDO: R1, R2, R3, ALQUILO INFERIOR O ARILO Y X ARILO. SE UTILIZA PARA TRATAR LA OSTEOPOROSIS Y OSTEODISTROFIA.
ES548910A 1984-11-16 1985-11-15 Un procedimiento para la preparacion de delta 22 o delta 23 -26,-26,26,27,27,27-hexafluoro-1alfa,25-dihidroxicolecalci- ferol Expired ES8801198A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/672,059 US4613594A (en) 1984-11-16 1984-11-16 Fluorinated vitamin D3 compounds

Publications (2)

Publication Number Publication Date
ES548910A0 ES548910A0 (es) 1987-12-16
ES8801198A1 true ES8801198A1 (es) 1987-12-16

Family

ID=24696990

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548910A Expired ES8801198A1 (es) 1984-11-16 1985-11-15 Un procedimiento para la preparacion de delta 22 o delta 23 -26,-26,26,27,27,27-hexafluoro-1alfa,25-dihidroxicolecalci- ferol

Country Status (21)

Country Link
US (1) US4613594A (es)
EP (1) EP0182298B1 (es)
JP (1) JPS61122237A (es)
KR (1) KR930007993B1 (es)
AR (1) AR242767A1 (es)
AT (1) ATE48412T1 (es)
AU (1) AU588012B2 (es)
CA (1) CA1286693C (es)
DE (1) DE3574587D1 (es)
DK (1) DK159652C (es)
ES (1) ES8801198A1 (es)
FI (1) FI84599C (es)
HU (1) HU194162B (es)
IE (1) IE58851B1 (es)
IL (1) IL77052A (es)
MC (1) MC1709A1 (es)
NO (1) NO162906C (es)
NZ (1) NZ214175A (es)
PH (1) PH21540A (es)
PT (1) PT81502B (es)
ZA (1) ZA858151B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63196556A (ja) * 1987-02-10 1988-08-15 Taisho Pharmaceut Co Ltd 含フツ素ビタミンd誘導体
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
AU5185790A (en) * 1989-02-16 1990-09-05 University Of Georgia Research Foundation, Inc., The Treatment of tibial dyschondroplasia
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンd▲下3▼類固型製剤
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5278155A (en) * 1991-06-05 1994-01-11 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and cell differentiation-inducing agent containing the same
DE69213844T2 (de) * 1991-07-05 1997-04-10 Duphar Int Res Vitamin-D Derivat, Verfahren zu dessen Herstellung sowie Zwischenprodukte dafür
US5753638A (en) * 1992-10-07 1998-05-19 Hoffmann-La Roche Inc. Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5547947A (en) * 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
JP2008519808A (ja) 2004-11-12 2008-06-12 ビオエクセル エスピーエー 膀胱癌治療のためのビタミンd誘導体及び抗増殖薬の併用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
JPS57149224A (en) * 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
US4358406A (en) * 1981-07-27 1982-11-09 Wisconsin Alumni Research Foundation 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
ATE34977T1 (de) * 1983-01-28 1988-06-15 Hoffmann La Roche Verfahren zur herstellung von cholecalciferolderivaten.
US4508651A (en) * 1983-03-21 1985-04-02 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
US4505906A (en) * 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US4521410A (en) * 1984-05-03 1985-06-04 The General Hospital Corporation Vitamin D glycosyl orthoesters

Also Published As

Publication number Publication date
ZA858151B (en) 1986-06-25
FI84599C (fi) 1991-12-27
DK159652B (da) 1990-11-12
NO854576L (no) 1986-05-20
AU5089885A (en) 1986-05-29
IE58851B1 (en) 1993-11-17
PH21540A (en) 1987-11-16
ES548910A0 (es) 1987-12-16
FI854492A (fi) 1986-05-17
FI854492A0 (fi) 1985-11-14
FI84599B (fi) 1991-09-13
IL77052A0 (en) 1986-04-29
NZ214175A (en) 1989-04-26
KR930007993B1 (ko) 1993-08-25
PT81502A (en) 1985-12-01
AU588012B2 (en) 1989-09-07
EP0182298A1 (de) 1986-05-28
JPH051770B2 (es) 1993-01-11
ATE48412T1 (de) 1989-12-15
KR860004073A (ko) 1986-06-16
DE3574587D1 (de) 1990-01-11
DK524585A (da) 1986-05-17
IE852875L (en) 1986-05-16
US4613594A (en) 1986-09-23
JPS61122237A (ja) 1986-06-10
HUT39138A (en) 1986-08-28
MC1709A1 (fr) 1986-09-22
PT81502B (pt) 1988-03-03
NO162906C (no) 1990-03-07
CA1286693C (en) 1991-07-23
AR242767A1 (es) 1993-05-31
NO162906B (no) 1989-11-27
DK159652C (da) 1991-04-08
DK524585D0 (da) 1985-11-13
IL77052A (en) 1990-02-09
HU194162B (en) 1988-01-28
EP0182298B1 (de) 1989-12-06

Similar Documents

Publication Publication Date Title
HUT68247A (en) Process for production of 1,5-diaryl-3-substituted-pyrazoles and preparations containing theese compounds
HUT39086A (en) Process for coating pharmaceutical preparations
HUT37410A (en) Process for the production of benzothiazole- and benzothiophene-derivatives, as well as of therapeutic preparations containing them as agent
HUT40579A (en) Process for preparing new pharmaceutical preparations of local application
EP0263569A3 (en) 9-alpha-hydroxysteroids,process for their preparation,process for the preparation of the corresponding 9(11)-dehydro-derivatives and pharmaceutical preparations containing said steroids
HUT42321A (en) Process for preparing pharmaceutical compositions
HUT40567A (en) Process for preparing stable nicorandyl preparations
ES8801198A1 (es) Un procedimiento para la preparacion de delta 22 o delta 23 -26,-26,26,27,27,27-hexafluoro-1alfa,25-dihidroxicolecalci- ferol
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
DE3067258D1 (en) Substituted 3-amino-sydnonimines, process for their synthesis and pharmaceutical preparations containing them
GR3001097T3 (en) 4-quinolone-3-carboxylic-acid derivatives, process for their synthesis and pharmaceutical preparations containing them
HUT41021A (en) Process for preparing indole derivatives and pharmaceutical preparations containing the same
DE3361610D1 (en) Enzyme derivatives, process for preparing them and pharmaceutical compositions containing them
DE3573428D1 (en) Novel delta4- and delta5- androstene derivatives, processes for their preparation and pharmaceutical compositions containing these derivatives
GB2106109B (en) Novel polycyclic polyazaheterocycles, processes for their manufacture and pharmaceutical preparations containing them
SG59992G (en) Dihydroorotic acid derivatives,processes for their preparing and pharmaceutical composition containing them
PT77657A (en) Processes for preparing novel heterocyclyl compounds and pharmaceutical preparations containing these compounds
LTIP1682A (en) Novel 16,17-acetal-substituted derivatives of pregnan-21-oic acid, process for preparing thereof, pharmaceutical preparations containing them
DE3162256D1 (en) Substituted phenoxy-aminopropanol derivatives, intermediates and processes for their production, and pharmaceutical preparations containing them
HUT44753A (en) Process for producing gem-dihalogen-1,8-diamino-4-azaoctane derivatives and pharmaceutical preparations comprising such compounds
ZA855245B (en) Aminoeburnanecarboxylic acid derivatives,pharmaceutical compositions containing them and process for preparing same
IL65541A0 (en) Alkylamino-2-propanols,process for their preparation and pharmaceutical preparations containing same
ZA815621B (en) Novel polyazaheterocyclic compounds,process for their manufacture and pharmaceutical preparations containing them
ZA855244B (en) Nitrovincaminic acid derivatives,pharmaceutical compositions containing them and process for preparing same
ZA79365B (en) Novel azathianaphthalene derivatives,process for their manufacture,pharmaceutical preparations containing them and their use